2011•Zhongguo linchuang yaolixue yu zhiliaoxueRequires access

Study on the escitalopram combined with low dose of aripiprazole in the treatment of depression with somatic symptoms

LV Bo-jun

Open publisher page 0 citations

Abstract

AIM: To explore the clinical efficacy of escitalopram combined with low dose of aripiprazole in the treatment of depression with somatic symptoms. METHODS: Eighty patients suffering from depression with somatic symptoms were randomly divided into study group(n=41) and control group(n=39),who received either escitalopram combined with low dose of aripiprazole or escitalopram only,respectively.The clinical efficacy and safety were evaluated with Hamilton Depression Rating Scale(HAMD),Self-rating Depression Scale(SDS),Clinical Global Impression(CGI),Treatment Emergent Symptom Scale(TESS) and Dysfunctional Attitudes Scales(DAS) at the point of baseline and the 1st,2nd,4th and 8th weekend.Meanwhile,the medication compliance and symptom recrudescence rate of two groups were also assessed in 3 months.RESULTS:Scores of HAMD,SDS and CGI decreased in both groups,but more significantly and quickly in study group.There was no difference between two groups in TESS.Patients in study group had better compliance,fewer symptom recrudescence rate and lower scores in DAS in 3 months,compared with control group.CONCLUSION: Escitalopram combined with low dose of aripiprazole works better in the treatment of depression with somatic symptoms than using escitalopram only.

About this research paper

What this paper is about

AIM: To explore the clinical efficacy of escitalopram combined with low dose of aripiprazole in the treatment of depression with somatic symptoms. METHODS: Eighty patients suffering from depression with somatic symptoms were randomly divided into study group(n=41) and control group(n=39),who received either escitalopram combined with low dose of aripiprazole or escitalopram only,respectively.The clinical efficacy and safety were evaluated with Hamilton Depression Rating Scale(HAMD),Self-rating Depression Scale(SDS),Clinical Global Impression(CGI),Treatment Emergent Symptom Scale(TESS) and Dysfunctional Attitudes Scales(DAS) at the point of baseline and the 1st,2nd,4th and 8th weekend.Meanwhile,the medication compliance and symptom recrudescence rate of two groups were also assessed in 3 months.RESULTS:Scores of HAMD,SDS and CGI decreased in both groups,but more significantly and quickly in study group.There was no difference between two groups in TESS.Patients in study group had better compliance,fewer symptom recrudescence rate and lower scores in DAS in 3 months,compared with control group.CONCLUSION: Escitalopram combined with low dose of aripiprazole works better in the treatment of depression with somatic symptoms than using escitalopram only.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM: To explore the clinical efficacy of escitalopram combined with low dose of aripiprazole in the treatment of depression with somatic symptoms. METHODS: Eighty patients suffering from depression with somatic symptoms were randomly divided into study group(n=41) and control group(n=39),who received either escitalopram combined with low dose of aripiprazole or escitalopram only,respectively.The clinical efficacy and safety were evaluated with Hamilton Depression Rating Scale(HAMD),Self-rating Depression Scale(SDS),Clinical Global Impression(CGI),Treatment Emergent Symptom Scale(TESS) and Dysfunctional Attitudes Scales(DAS) at the point of baseline and the 1st,2nd,4th and 8th weekend.Meanwhile,the medication compliance and symptom recrudescence rate of two groups were also assessed in 3 months.RESULTS:Scores of HAMD,SDS and CGI decreased in both groups,but more significantly and quickly in study group.There was no difference between two groups in TESS.Patients in study group had better compliance,fewer symptom recrudescence rate and lower scores in DAS in 3 months,compared with control group.CONCLUSION: Escitalopram combined with low dose of aripiprazole works better in the treatment of depression with somatic symptoms than using escitalopram only.

Key concepts: Escitalopram, Aripiprazole, Clinical Global Impression, Depression (economics), Hamd, Rating scale, Internal medicine, Psychology

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on the escitalopram combined with low dose of aripiprazole in the treatment of depression with somatic symptoms — Research Paper | ScholarLens